The N-terminus of IpaB provides a potential anchor to the Shigella type III secretion system tip complex protein IpaD by Dickenson, Nicholas E. et al.
The N-terminus of IpaB provides a potential anchor to the
Shigella type III secretion system tip complex protein IpaD
Nicholas E. Dickenson§, Olivia Arizmendi‡, Mrinalini K. Patil‡, Ronald T. Toth IV†, C.
Russell Middaugh†, William D. Picking‡, and Wendy L. Picking‡,*
§Department of Chemistry and Biochemistry, Utah State University, Logan, UT 84322
‡Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK
74078
†Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center,
University of Kansas, Lawrence, Kansas 66047
Abstract
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri,
providing a conduit through which host-altering effectors are injected directly into a host cell to
promote uptake. The type III secretion apparatus (T3SA) is comprised of a basal body, external
needle, and regulatory tip complex. The nascent needle is a polymer of MxiH capped by a
pentamer of invasion plasmid antigen D (IpaD). Exposure to bile salts (e.g. deoxycholate) causes a
conformational change in IpaD and promotes recruitment of IpaB to the needle tip. It has been
proposed that IpaB senses contact with host cell membranes, recruiting IpaC and inducing full
secretion of T3SS effectors. While the steps of T3SA maturation and their external triggers have
been identified, details of specific protein interactions and mechanisms have remained difficult to
study due to the hydrophobic nature of the IpaB and IpaC translocator proteins. Here we explored
the ability for a series of soluble N-terminal IpaB peptides to interact with IpaD. We found that
DOC is required for the interaction and that a region of IpaB between residues 11–27 is required
for maximum binding, which was confirmed in vivo. Furthermore, intramolecular FRET
measurements indicated that movement of the IpaD distal domain away from the protein core
accompanied the binding of IpaB11-226. Together these new findings provide important new
insight into the interactions and potential mechanisms that define the maturation of the Shigella
T3SA needle tip complex and provide a foundation for further studies probing T3SS activation.
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Shigella species cause a severe form of bacillary dysentery (shigellosis) that is readily
spread via contaminated water. Shigellosis is of worldwide public health importance with an
estimated 90 million cases and 100,000 deaths per year with especially high incidence in
children in low income countries.1,2 Those children that survive suffer impaired growth due
to malnutrition which is exacerbated by repeated episodes.3 Shigellosis outbreaks also occur
on a regular basis in industrialized nations and the emergence of antibiotic resistant strains
underscores the necessity for better understanding the virulence mechanism of Shigella.4
Shigella employs a type III secretion system (T3SS) as its primary virulence factor.5 The
type III secretion apparatus (T3SA) resembles a nano-syringe and needle and provides a
physical link between the Shigella and the gastrointestinal epithelial cell.5 It is comprised of
three main components: the basal body which spans the inner and outer bacterial membranes
serving as an anchor for the apparatus and providing a conduit through the bacterial
envelope; an external needle, with an outer diameter of 7 nm with a 2.5 nm inner channel,
consisting of multiple copies of a MxiH packed in a helical manner;6 and an exposed tip
complex consisting of a pentamer of invasion plasmid antigen D (IpaD).7,8 IpaD serves as a
sensor of environmental small molecules such as bile salts to control the context of the tip
complex and secretion of effector proteins. Exposure to the bile salt dexoycholate (DOC)
promotes recruitment of the first hydrophobic translocator, IpaB, to the maturing tip
complex where an organized oligomer forms the translocon pre-pore.9,10 From this exposed
position, it has been proposed that IpaB can sense host membrane components, triggering
recruitment of the second hydrophobic translocator, IpaC, to the Shigella exterior.11 This
completes formation of the translocon pore in the host cell membrane and induces secretion
of T3SS host-altering effectors into the cell to promote pathogen entry.11
Although Shigella has provided a valuable system for identifying the steps encompassing
T3SA tip complex maturation, the precise mechanisms and protein interactions that govern
this process remain unknown. Recent studies have started to unravel some of these
mechanisms by identifying an IpaD conformational change that occurs upon DOC binding.
It is proposed that this conformational change allows IpaB access to the maturing needle tip
where it associates with IpaD.12,13 To date, verifying a direct association between IpaD and
IpaB has been challenging due, in part, to the requirement of detergent to maintain soluble
IpaB in aqueous conditions.
Previously, we generated stable IpaB N-terminal fragments that could be expressed in the
absence of the cognate IpaB chaperone IpgC and are highly soluble in aqueous
conditions.14,15 In this study, we used these and additional IpaB fragments to explore
conditions that may allow their stable interaction with purified IpaD. Fluorescence
polarization (FP) and Förster resonance energy transfer (FRET) were employed to
demonstrate that specific N-terminal fragments of IpaB are capable of binding with strong
affinity to IpaD in a DOC dependent manner. Furthermore, we found that a short peptide
sequence located near the N-terminus of IpaB is necessary for optimal binding. This region
has recently been identified as one of two likely binding domains important for IpaB
association with its chaperone IpgC,15,16 suggesting there is a direct competition for binding
at this site by IpaD and IpgC within the bacterial cytoplasm. Intramolecular FRET
measurements revealed a relationship between DOC binding, flexibility within the IpaD
distal domain, and the interaction between IpaD and IpaB. Overall, these data provide the
first direct evidence of an IpaD-IpaB interaction in vitro and valuable mechanistic insight
into this interaction. Generation of several N-terminal mutations in wild-type IpaB provided
a correlation between the in vitro binding studies and virulence Shigella phenotypes in vivo.
The resulting findings suggest that regions near the N-terminus of IpaB are necessary for its
interaction with IpaD and the sequential maturation of the T3SA needle tip. As the first step
in T3SA tip complex maturation and a prerequisite for the ability of Shigella to invade host
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cells, determining the biochemical basis for the interaction between IpaD and IpaB provides
a valuable contribution toward understanding the molecular basis for the onset of type three
secretion induction in Shigella with ramifications that extend to related T3SSs. This could,
in turn, help in the development of anti-infective measures against not only Shigella, but




The Shigella flexneri ipaB null strain SF620, was provided by P.J. Sansonetti (Pasteur
Institute, FR).17 E. coli strains, protein expression plasmids, and Clonables 2X Ligation
Premix were from Novagen (Madison, WI). Restriction enzymes were from New England
Biolabs (Ipswich, MA). Alexa Fluor probes, fluorescein maleimide (FM), 7-
Diethylamino-3-(4′-Maleimidylphenyl)-4-Methylcoumarin (CPM), and FlAsH-EDT2 were
from Invitrogen (Carlsbad, CA). Oligonucleotide primers were purchased from Integrated
DNA Technologies (Coralville, IA). Iminodiacetic acid-Sepharose was from Sigma
Chemical Company (St. Louis, MO). All other solutions and chemicals were reagent grade.
Plasmid constructs and expression of ipaB and ipaD
Wild-type ipaD and ipaD made to encode a tetracysteine binding pocket (the amino acid
sequence CCPGCC) within the distal domain were produced as described previously.13 The
N-terminal IpaB peptides were generated in the plasmid pT7HMT or a modified version of
the plasmid that introduced an N-terminal cysteine and expressed as previously
described.14,18 Mutations encoding the IpaB internal cysteine point mutants used for FRET
were introduced into both full length ipaB and ipaB11-226 using 5′ phosphorylated primers
and inverse PCR. Residues 107, 120, 128, and 149 were chosen because they provide a mild
mutation from serine to cysteine and all reside within the backbone of the solved IpaB74-224
structure. For phenotypic characterization, the ipaB cysteine point mutants and deletion
mutants were generated in the plasmid pWPsf4 and electroporated into the Shigella flexneri
ipaB null strain, SF620. For protein expression, the cysteine mutants generated in IpaB11-226
were cloned into pT7HMT and the IpaB N-terminal deletion mutants were subcloned into
pET15b. The N-terminal IpaB fragments containing an N-terminal cysteine were generated
using a modified version of the pT7HMT expression plasmid.18 The resulting plasmids were
introduced into E. coli Tuner(DE3). All of the E. coli Tuner(DE3) strains were grown at 37
°C in Terrific Broth to an OD600 of 1.0, protein expression induced with 1mM IPTG for 18
hours at 17 °C and the recombinant protein purified using standard nickel chelation
chromatography as previously described.14
Characterization of novel IpaB peptides and mutants
The secondary structures and thermal stabilities of IpaB1-226 and IpaB28-226 were previously
published.15 The intermediate peptide, IpaB11-226, the IpaB N-terminal deletion mutants,
and the four cysteine point mutants generated for this study were also analyzed by far-UV
CD using a Jasco Model J-815 spectropolarimeter equipped with a Peltier temperature
controller (Jasco Inc., Easton, MD). Secondary structure content was assessed by collecting
CD spectra from 190 nm to 260 nm at 10 °C using a 0.1 cm quartz cuvette. A scanning rate
of 50 nm/min was used with a spectral resolution of 0.2 nm and a 2-sec data integration
time. All spectra are an average of three measurements. The proteins’ secondary structure
thermal stability was determined by monitoring the CD signal at 222 nm over a temperature
range from 10 °C to 90 °C. The CD signal was acquired every 2.5 °C as the temperature was
increased at a rate of 15 °C/h and maintained at each interval for one minute to allow the
solution temperature to equilibrate. The protein concentration was 0.3–0.5 mg/mL in 10 mM
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phosphate (pH 7.4) with 150 mM NaCl (PBS) for all proteins and measurements were
normalized by converting the output signal to mean residue molar ellipticity.
Phenotypic characterization of IpaB mutants
Three independent assays were used to characterize the effect of IpaB mutations.8 First, the
effect of the IpaB mutations on the invasive capacity of Shigella was monitored using HeLa
cells in a standard gentamycin protection assay using SF620 expressing wild-type ipaB as
the positive control (100% invasion). Second, the ability of Shigella to form a translocon
pore through proper recruitment of the translocator proteins IpaB and IpaC can be
determined by contact-mediated hemolysis. SF620 expressing the IpaB mutants were tested
for their contact hemolytic activity and compared to SF620 expressing wild-type ipaB
(100% contact mediated hemolysis). Third, uninduced secretion profiles measure the T3SA
control of secretion during regular growth. The uninduced secretion of IpaD, IpaB, and IpaC
into the culture media during overnight growth was assessed by Western blotting. Blots
were probed with a primary antibody mixture containing mouse anti-IpaD, rabbit anti-IpaB,
and rabbit anti-IpaC polyclonal antibodies and the corresponding Alexa Fluor 680 goat anti-
rabbit IgG and Alexa Fluor 800 goat anti-mouse IgG (Molecular Probes, Eugene, OR).
Images were obtained using an Odyssey Infrared Imager (LI-COR, Lincoln, NE).
Labeling of recombinant protein with fluorescent probes
The N-terminal cysteine introduced into IpaB peptides or the corresponding internal cysteine
in the IpaB11-226 point mutants were fluorescently labeled with FM. The purified proteins
were dialyzed into 50 mM HEPES (pH 7.2), 140 mM NaCl, and 2.5 mM TCEP and
degassed under N2. FM prepared in N′,N′-dimethylformamide (DMF) was added to
approximately a 10 molar excess to an aliquot of the protein and allowed to react for 2 h at
room temperature under N2. The unbound dye was removed by nickel chelation
chromatography, the labeled protein eluted and dialyzed into PBS. The native cysteine of
IpaD (residue 322) was labeled with the thiol-reactive 7-diethylamino-3-(4′-
maleimidylphenyl)-4-methylcoumarin (CPM) as described previously.19 Protein secondary
structure and thermal stability were verified by far-UV CD spectroscopy. Because of
interference with CD signals after fluorescence labeling, the retention of structural features
for labeled IpaB fragments was determined by Fourier-transform infrared (FTIR)
spectroscopy. The infrared spectrum of each sample was collected at room temperature
using a Vertex 70 FTIR spectrometer (Bruker Corp., Billerica, MA) using a BioATR cell
(Harrick Scientific, Pleasantville, NY). The data were collected from 256 composite scans
over a range of 4000 cm−1 to 900 cm−1 with a resolution of 4 cm−1.
For the intramolecular FRET analysis, the CCPGCC tetracysteine motif introduced into the
distal domain of purified IpaD was labeled with FlAsH-EDT2 (a biarsenical fluorescein
reagent that coordinates with the above tetracysteine motif) as described previously.13 Both
the donor only FlAsH-labeled IpaD and the donor and acceptor doubly-labeled IpaD were
dialyzed into PBS and used within one week or stored at −80 °C.
Fluorescence polarization
The FM-labeled N-terminal cysteine mutants of IpaB1-226, IpaB11-226, and IpaB28-226 were
diluted to 80 nM in PBS and IpaD was titrated in at concentrations from 0 to 10 μM. The
mixtures were incubated 30 min at room temperature and the fluorescence polarization of
the IpaB-bound fluorescein was measured using a Molecular Devices SpectraMax M5
fluorescence plate reader equipped with excitation and emission polarizers. The polarization
was measured in 96 well opaque plates using an excitation wavelength of 490 nm and
emission wavelength of 527 nm. The measurements were repeated following the addition of
either 1 mM DOC or the synthetic bile salt dehydrocholate (DHC). These measurements
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were also used to test the binding of the IpaB11-226 peptide to the IpaD homologs SipD
(from Salmonella enterica)20 and LcrV (from Yersinia pestis).21 SigmaPlot 11.2 was used to
plot the change in polarization as a function of IpaD (or homolog) concentration and the data
were fit to a single-site saturation ligand binding equation to estimate the dissociation
constant (Kd) for each interaction.
Förster resonance energy transfer (FRET) measurements
Fluorescence emission spectra of the FRET systems were collected at 20 °C with a
FluoroMax-4 spectrofluorometer (HORIBA Jobin Yvon, Edison, NJ) (see Ref22 for a
detailed description of FRET). For the detection of intermolecular FRET between IpaD and
the IpaB11-226 cysteine point mutants, the excitation wavelength was 385 nm (specific for
the coumarin donor) and emission was collected from 400–600 nm with an integration time
of 0.05 sec. Donor-labeled IpaD (125 nM) was incubated with 1 μM of each IpaB11-226
cysteine mutant either labeled with a fluorescein FRET acceptor (DA) or not (D only).
Fluorescence emission spectra were collected for both conditions prior to and following 30-
min incubation with 1 mM DOC at 20 °C to observe the effects of DOC on the IpaD/IpaB
interaction. Intramolecular FRET measurements between the acceptor-labeled native
cysteine in IpaD and the donor-labeled tetracysteine binding pocket engineered into the
distal domain were acquired similarly using an excitation wavelength of 485 nm (specific
for the FlAsH donor) and emission collected from 500–650 nm with an integration time of
0.05 seconds. Spectra were collected for 125 nM solutions of both IpaD labeled only with
the FlAsH donor (D only) and IpaD dually-labeled with the FlAsH donor and the Alexa 568
acceptor (DA). The IpaD was split and incubated 30 min with either a PBS control or 1 mM
DOC in PBS at 20 °C prior to titrating in IpaB11-226 to 5 μM. The resulting data points were
fit to a Hill1 binding model used to estimate the Kd of the interaction.
Calculating energy transfer efficiencies between FRET pairs
FRET efficiencies were measured spectrophotometrically, as described above, and
calculated by quantifying the reduction in donor fluorescence intensity when in the presence
of an acceptor.13,15 For this method, it is important that the donor concentration and labeling
efficiency remain identical in the conditions of donor only and donor in the presence of
acceptor to ensure that the change in observed donor fluorescence intensity is solely due to
FRET. This was achieved for the intermolecular FRET measurements because either
acceptor-labeled or non-labeled ligand is added to the donor-labeled protein, ensuring that
the donor conditions remain unchanged. For intramolecular FRET measurements, this is
accounted for because the donor only sample was split just prior to labeling of the protein
with the FRET acceptor. Thus, for both techniques the labeling efficiencies of the donor
only and donor-acceptor conditions are identical and the energy transfer efficiencies can be
calculated by:23
Eq.1
where E is the energy transfer efficiency, FD is the peak donor fluorescence intensity in the
absence of the FRET acceptor, and FDA is the peak donor fluorescence intensity in the
presence of the FRET acceptor. Because the energy transfer efficiency is sensitive to the
distance separating the FRET pair, comparing these efficiencies provides insight into
changes in the spatial relationship between the donor and acceptor.
In vivo Shigella surface localization of IpaB
The ability of IpaB mutants to stably localize to the tip of the T3SA was determined by flow
cytometry. Shigella were grown to an OD600 = 0.4 prior to the addition of 1 mg/mL DOC to
the cultures. The bacteria were allowed to grow an additional 30 min, collected by
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centrifugation, washed with PBS, and fixed by resuspension in freshly prepared 4%
paraformaldehyde in PBS. The fixed cells were rinsed and diluted to ~5 × 108 bacteria/mL,
blocked with a 1:1 mixture of Odyssey blocking buffer:PBS prior to addition of appropriate
primary antibodies. The samples were incubated at room temperature for 2 h, rinsed, and
incubated with Alexa Fluor 488 conjugated goat anti-rabbit secondary IgG for 1 h, rinsed
again and diluted in PBS. The samples were then analyzed using a FACSCalibur flow
cytometer set to collect 500,000 events for each mutant (BD Biosciences, San Jose, CA).
The results were plotted and analyzed using FlowJo V10.0.6 (Tree Star, Ashland, OR).
Results
Deoxycholate promotes an interaction between IpaD and N-terminal IpaB peptides in vitro
Previous protease digestion studies identified several stable core fragments of the highly
hydrophobic Shigella translocator IpaB.14 Most of the stable regions clustered near the IpaB
N-terminus with IpaB28-226 being used to solve a 2.1 Å structure for IpaB74-224.14 Insights
from this structure and the generation of soluble IpaB peptides capable of being expressed in
the absence of IpgC have played an important role in dissecting interactions between IpaB
and IpgC.15 In this study, the cysteine residues introduced at the N-terminal extremity of the
stable IpaB fragments IpaB1-226, IpaB11-226, and IpaB28-226 were covalently labeled with a
fluorescent probe to allow the use of fluorescence polarization (FP) to identify conditions
that would permit their interaction with IpaD in vitro. Incubating each IpaB fragment with
up to a 125-fold excess of IpaD (10 μM) in an aqueous buffer system resulted in essentially
no change in polarization, suggesting that no interaction was occurring (Fig. 1A, open
symbols). Following a 30-min incubation in the presence of 1 mM DOC, however, each
labeled IpaB species demonstrated an IpaD-dependent increase in FP (Fig. 1A, filled
symbols). This change in FP was seen as an initial sharp rise in polarization, indicating that
an interaction was occurring. Interestingly, while the apparent Kd values for the interaction
between IpaD and IpaB1-226 and IpaB11-226 in the presence of DOC were below 1 μM, the
binding between IpaB28-226 and IpaD was significantly weaker with an apparent Kd of 3.60
μM (Table 1), suggesting that a region within IpaB residues 11–27, together with DOC, play
an important role in the interaction between IpaD and IpaB.
The specificity of DOC in promoting the interaction was tested by substituting DHC for
DOC. Though structurally similar to DOC, DHC has been shown to neither interact with
IpaD nor promote a conformational change within the protein.13,19 Here, the addition of
DHC resulted in no detectable binding of any of the IpaB fragments to IpaD (Supplementary
Fig. S1A), supporting a specific DOC-dependent interaction rather than a non-specific
detergent or small molecule effect. These results are consistent with the inability of DHC
exposure to increase S. flexneri invasiveness of cultured cells. While exposure to 1 mM
DOC substantially increased invasiveness, the addition of DHC had little effect, actually
resulting in a slight decrease in invasion (Supplementary Table S1).
It is worth noting that although all three IpaB peptides could be expressed, purified, and
fluorescently labeled at high levels, we found that IpaB11-226 was stable longer (by SDS-
PAGE) than the IpaB1-226 peptide (data not shown). Although comparison of CD spectra of
the IpaB peptides do not suggest significant differences in secondary structure
(Supplementary Fig. S2 and reference15), IpaB11-226 was selected over IpaB1-226 for use in
the remainder of the in vitro studies for this observed stability.
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Deoxycholate promotes binding of IpaB11-226 to the IpaD homolog Salmonella SipD but not
Yersinia LcrV
To test the specificity for the observed IpaD-IpaB interaction, FP was used to determine the
ability of IpaB11-226 to bind the homologous T3SS tip proteins SipD from Salmonella and
LcrV from Yersinia. As with IpaD, no change in the polarization of labeled IpaB11-226 was
observed following a 30-min incubation with either of these recombinant proteins (Fig. 1B).
The addition of 1 mM DOC failed to promote an interaction between IpaB11-226 and LcrV
under any observed conditions and is likely attributed to its divergence from IpaD in both
primary24 and tertiary structure.24,25 Titration of SipD in the presence of 1 mM DOC,
however, resulted in binding (Fig. 1B) with an estimated dissociation constant of 1.71 μM,
approximately four-fold weaker than the Kd for the interaction between IpaD and
IpaB11-226. Association with SipD might be expected due to similarities in their primary
sequences24, however, the IpaB and SipB N-terminal regions differ rather substantially with
regard to sequence despite having notable structural similarity.14 Although weaker than the
IpaD/IpaB11-226 interaction, the SipD/IpaB11-226 interaction exhibits a similar specificity for
DOC since DHC fails to promote binding between SipD and IpaB11-226 (Supplementary Fig.
S1B). While DOC binding to SipD with a concomitant conformational change has been
reported by others,26,27 there has not been a direct physiological link between DOC and
changes in the Salmonella T3SA needle tip composition. In fact, growth in DOC decreases
the invasiveness of Salmonella due, in part, to a down-regulation of gene expression.28
Interestingly, however, short term (1 min) exposure of a mid-log culture to this bile salt also
results in a decrease in invasion phenotype, which cannot be entirely contributed to down-
regulation of gene expression (data not shown).
Intermolecular FRET provides additional insight into the association of IpaD with the IpaB
N terminus
Förster resonance energy transfer (FRET) was measured between the CPM-labeled native
cysteine (residue 322) of IpaD and the fluorescein-labeled cysteine residue introduced
individually into each of four positions within IpaB11-226 (S107C, S120C, S128C, and
S149C) (Fig. 2A and 2B, respectively). The introduction of each of these cysteine mutations
had little impact on secondary structure/stability of the IpaB11-226 (Supplementary Fig. S2)
and each mutation gave rise to a readily detectable invasive phenotype when introduced into
full length IpaB and expressed in S. flexneri SF620 (Supplementary Table S2). FTIR
analysis was used to compare the relative structure structural composition of unlabeled and
fluorescein-labeled IpaB11-226 S128C (Supplementary Fig. S3).24,29 No difference in overall
protein structure was detected, suggesting that the addition of the fluorescein probe does not
have an adverse effect on the protein structure. FRET efficiency between the donor-labeled
IpaD and each of the acceptor-labeled IpaB11-226 mutants was determined by quantifying
the decrease in donor fluorescence in the presence of a FRET acceptor (see Fig. 2C). The
measured energy transfer efficiencies between the donor-labeled IpaD and all of the
acceptor-labeled IpaB11-226 cysteine mutants were minimal in the absence of DOC, which is
consistent with the absence of an interaction (Table 2). After adding DOC, however, the
measured FRET efficiencies increased, indicating the induction of an interaction between
IpaD and the IpaB mutants (Table 2). When the Yersinia tip protein, LcrV, was substituted
for IpaD in these experiments as a negative control, FRET efficiencies of ≤ 6.5% were
calculated for all conditions and the addition of 1 mM DOC resulted in a change in FRET
efficiencies of no more than 3.3% (data not shown), validating the technique and confirming
the lack of interaction between LcrV and IpaB11-226 seen in the fluorescence polarization
measurements. The FRET efficiencies between the donor-labeled Cys322 of IpaD and
acceptor-labeled Cys107 and Cys120 in IpaB11-226 were both approximately 33% and the
values decreased to 21.4% and 14.6% as the acceptor moved to Cys128 and Cys149,
respectively, (Fig. 2A and B, Table 2) suggesting that the donor fluorophore on IpaD was
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nearest to and approximately equidistant from the acceptor at positions 107 and 120 on
IpaB11-226. The acceptor probes at positions 128 and 149 then appeared to be located
progressively further from the donor probe on IpaD, providing initial insight into the
interaction between the proteins.
Intramolecular FRET implicates DOC in regulating IpaB interaction with IpaD via a
conformation change within the IpaD distal domain
Recent EM reconstructions have demonstrated that the IpaD distal domain assumes an
upward position within the context of the pentamer formed at the Shigella T3SA needle tip.7
Therefore, we designed an intramolecular FRET system that is sensitive to movement of the
IpaD distal domain relative to the native cysteine at the bottom of the central coiled coil.
This would allow us to determine whether association with IpaB11-226 is consistent with an
upward movement of the IpaD distal domain (Fig. 3A). The FRET efficiency between the
donor fluorophore at Cys322 (CPM) and the acceptor in the distal domain (FlAsH probe at
position TC231) was determined based on the extent of donor quenching as for the
intermolecular FRET described above. The measured energy transfer efficiencies followed a
dose-dependent decrease with the titration of IpaB11-226, indicating that the average position
of the IpaD distal domain is directly affected by IpaB11-226 binding (Fig. 3B). In the absence
of DOC, however, titration of IpaB11-226 has little effect on the measured intramolecular
FRET efficiencies, supporting the idea that DOC promotes a stable IpaD/IpaB11-226
interaction. Addition of 5 μM LcrV in place of IpaB11-226 failed to produce a change in
intramolecular FRET efficiency in either the presence or absence of DOC, indicating a level
of specificity for IpaB (data not shown). Moreover, fitting the FRET efficiencies as a
function of IpaB11-226 concentration (1 mM DOC) to a Hill1 binding model with an adjusted
R2 value of 0.990, allowed us to calculate an apparent Kd value of 365 nM. The striking
similarity of the Kd determined here and the Kd determined by FP (378 nM) suggests that
the location of the IpaD distal domain is not only linked to the binding of IpaB, but that the
correlation can be used as a direct measure of interaction. It is worth noting that while this
method for measuring FRET efficiencies provides a reliable tool sensitive to Angstrom-level
structural changes in the protein conformation, absolute FRET efficiencies and distances are
difficult to quantify. This is evident as the FRET efficiencies reported here are
approximately 20% lower than those reported previously,13 however, the addition of DOC
once again resulted in a measured decrease in FRET efficiency which was exaggerated upon
the binding of IpaB11-226.
Role of the N-terminus of IpaB in formation of the IpaD/IpaB complex
While the fluorescence data, as a whole, provide evidence for an interaction between IpaD
and the N-terminal fragments of IpaB, the FP data identify a key region in IpaB that may be
responsible for a maximal IpaD/IpaB interaction (IpaB11-27). We therefore used the
secondary structure prediction program PSIPRED30 to guide in the design of deletion
mutants within this region of full length IpaB for in vivo analysis (Supplementary Fig. S4).
Three mutants, IpaBΔ12-19, IpaBΔ12-25, and IpaBΔ12-27, were designed to probe the roles of
specific elements of this region by taking into account the predicted secondary structure
components (Supplementary Fig. S4) and maintaining the proposed secretion signal at the
extreme N-terminus.31 IpaBΔ12-27 mimics the in vitro studies which identified these residues
as instrumental in IpaD binding. The IpaBΔ12-19 and IpaBΔ12-25 mutants removed the first
predicted α-helix and the region containing this helix plus the adjacent coil, respectively.
The modified sequences were again analyzed by PSIPRED and while the IpaBΔ12-19 and
IpaBΔ12-25 mutants resulted in predicted secondary structures consistent with simply
removing the defined regions, the IpaBΔ12-27 mutant was predicted to extend the second
helix an additional five residues toward the N-terminus. The recombinant proteins
containing the indicated deletions were purified, analyzed by CD, and secondary structure
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contents estimated using the Dichroweb software package32,33 including the CDSSTR
algorithm.34 Each of the mutants were found to maintain secondary structure composition
and thermal stability characteristics similar to wild-type IpaB (Supplementary Fig. S5 and
Supplementary Table S3.
The ipaB null Shigella strain SF620 strain was complemented with the above deletion
mutants and the resulting virulence phenotypes characterized. The uninduced overnight
secretion profiles of the T3SA Ipa tip proteins showed that all of the mutants were expressed
and secreted at levels similar to SF620 complemented with full length ipaB, however IpaD
and IpaC were hypersecreted with levels similar to those of the ipaB null strain (Fig. 4A and
Supplementary Table S4), suggesting impaired secretion control by the IpaB deletion
mutants. Analysis of the profiles of the whole cell extracts shows a typical pattern expected
when a protein’s secretion is uncontrolled, resulting in decreased levels remaining in the
cytoplasm (Fig. 4B). The ability of the mutant complement strains to lyse erythrocytes
through translocon insertion and to invade cultured epithelial cells were tested by hemolysis
and gentamicin protection assays, respectively. Each of the mutants exhibited dramatically
reduced phenotypes when compared to the full length ipaB complemented strain (Table 3),
suggesting that while the mutants were expressed and secreted Fig. 4), they do not form a
functioning T3SA tip complex, likely due to the impaired ability for IpaB to interact
properly with IpaD.
The ability of IpaB and the IpaB deletion mutants to localize to the bacterial surface as a part
of the T3SA was tested by using flow cytometry to detect levels of selectively
immunolabeled IpaB. All of the strains were grown in the presence of 1 mM DOC to ensure
appropriate signaling for IpaB translocation. Five hundred thousand events were recorded
for each mutant and displayed as a histogram of fluorescence intensity (Fig. 5). The wild-
type complemented strain exhibited the highest overall fluorescence intensity while the
intensity of the IpaB deletion mutants was much lower and are nearly equivalent to those of
the IpaB null strain. Thus, these data further suggest that the deleted regions are involved in
maintaining a strong IpaD/IpaB interaction following DOC stimulation.
Discussion
Incubation of Shigella with the bile salt deoxycholate promotes recruitment of IpaB to the
maturing T3SA needle tip which correlates with an enhanced ability of the bacteria to
invade cultured epithelial cells.9 This and other work clearly define IpaD as an important
regulator of type III secretion from its position at the Shigella T3SA needle tip.35,36
Nevertheless, until now there has been no demonstration of a direct interaction between the
Shigella tip protein IpaD and the first hydrophobic translocator IpaB. In this study we used
fragments from the N-terminus of IpaB to demonstrate this interaction, its dependence on
DOC, and the involvement of a structural change in the IpaD distal domain using
complementary fluorescence spectroscopy methods. Initially, FP measurements confirmed
that DOC is required for the tested IpaB fragments to bind with IpaD, supporting the
proposal that a DOC-induced conformational change in IpaD has a role in promoting stable
maintenance of IpaB at the T3SA needle tip.9,12,13 Intermolecular FRET measurements
between a donor probe on IpaD and an acceptor at each of four individual sites on
IpaB11-226 then suggested that the N-terminal region of the coiled-coil in the solved
structure of IpaB resides near the “bottom” of the IpaD coiled-coil (see Fig. 2). The
intramolecular FRET results identified IpaB11-226-dependent changes in FRET efficiency
consistent with the IpaD distal domain moving further away from the C-terminus of IpaD
(flipping upward) upon binding IpaB11-226. This movement appears to be needed to
accommodate proper interaction with IpaB, possibly by a providing IpaB11-226 access to
previously inaccessible contact points (see Fig. 3A). While the precise role of DOC in this
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interaction and resulting movement of the distal domain remain unclear, previous work13
together with these findings suggests that the IpaD distal domain location relative to the C-
terminal cysteine is sensitive to DOC exposure and this exacerbated by the subsequent
interaction with IpaB.
We also found through the initial FP studies that IpaB residues 11-27 play an important role
in optimal binding to IpaD. We were able to confirm importance of this region in vivo and
further narrow down the region responsible by creating deletion mutants and characterizing
the resulting phenotype in S. flexneri. Hemolysis and invasion assays showed that loss of
this region is detrimental to Shigella virulence activities although the protein was expressed
at wild-type levels, was secreted through the T3SA (Fig. 4), and co-purified with IpgC when
co-expressed in E. coli (data not shown). Consistent with these results, fluorescence
immunolabeling of Shigella suggested that the IpaB mutants localized to the Shigella
surface (T3SA) much less efficiently than the wild-type protein (Fig. 5), likely a result of the
described deficiency in IpaD/IpaB interaction. Furthermore, it is worth noting that while
IpaB residues 11–27 appear essential for optimum IpaD interaction and Shigella virulence
mechanisms, we recently reported that a site within the N-terminal 27 residues of IpaB is
also necessary for optimal IpaB binding of its chaperone IpgC.15 Together, these studies
suggest that IpaD and IpgC share an overlapping binding region near the N-terminus of
IpaB, which acts to prevent a premature IpaD/IpaB interaction in the bacterial cytoplasm.
Unfortunately, we could not directly address whether IpgC and IpaD binding to the IpaB N-
terminal domain is competitive because while DOC is required for binding to IpaD, its
detergent properties favor dissociation of the IpaB/IpgC heterodimer (data not shown).
From the data presented here, we propose an in vitro model in which exposure of IpaD to
DOC induces a conformational change that generates the flexibility needed for the distal
domain to move from the position observed in the IpaD crystal structure to permit the IpaD
and IpaB coiled-coil cores to align parallel with one another. This is proposed to mimic the
in vivo interaction where DOC induces flexibility within the IpaD needle tip pentamer that
allows the individual five distal domains (already in an up position) to open up to allow
IpaB to move to a position where it is now surface exposed. While it seems unlikely that the
sole driving force for interaction between these two large proteins is a short peptide
sequence near the N-terminus of IpaB, both in vitro and in vivo studies presented here
suggest that a region as small as that from residues 12–19 in IpaB plays a crucial role in
optimizing this interaction. Further investigation into the nature of this interaction, the
proposed events leading up to this interaction, and its role in T3SA maturation is needed to
fully understand how needle tip maturation occurs and its contribution to Shigella virulence,
however, results from this study now provide a platform for addressing these questions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. N-terminal IpaB peptides require deoxycholate for optimal interaction with IpaD
A) Fluorescence polarization of fluorescein-labeled IpaB peptides (80 nM) was monitored as
the concentration of IpaD was increased from 0 to 10 μM. IpaD-dependent changes in
polarization were monitored for IpaB1-226 (●), IpaB11-226 (■), and IpaB28-226 (▲) following
incubation with 1 mM DOC or in the absence of DOC (corresponding open symbols). B)
The fluorescently-labeled Shigella IpaB11-226 was incubated with the T3SS tip proteins from
Salmonella (SipD, ◆) and Yersinia (LcrV, ▼) as well as IpaD (■) in the presence of 1 mM
DOC or the absence of DOC (corresponding open symbols). Each graph is representative of
three independent experiments with error bars indicating the standard deviation of triplicate
measurements within a single experiment. The results were fit with a single site saturation
model using SigmaPlot and the overlaid functions are included for those for which binding
occurred (R2 > 0.90).
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Figure 2. Using FRET to characterize the interaction between IpaD and IpaB
A) The FRET donor probe (CPM) was covalently bound to the thiol of the native IpaD
cysteine at position 322. Individual cysteine point mutations were introduced into IpaB11-226
at positions 107, 120, 128, and 149 to allow covalent attachment of a FRET acceptor probe
(FM) (B). Dashed circles with diameters equal to those of the fluorophores are included at
each labeling site. The FRET efficiency between the donor and acceptor was quantified for
each acceptor position in the absence and presence of 1 mM DOC based on donor
quenching. Panel C is a representative set of FRET donor emission spectra acquired for
coumarin-labeled IpaD in the presence of acceptor-labeled IpaB11-226 S107C (open
triangles) and unlabeled IpaB11-226 S107C (closed triangles). Spectra were re-acquired for
donor only and donor plus acceptor conditions following the addition of 1 mM DOC (open
circles and closed circles, respectively).
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Figure 3. IpaD distal domain movement accompanies IpaB binding
The locations of FlAsH FRET donor and Alexa Fluor 568 FRET acceptor probes are
identified at positions TC231 and Cys322, respectively. Dashed circles with diameters equal
to those of the fluorophores are included at each labeling site (A). Plotting IpaD
intramolecular FRET efficiency in the absence of DOC (◆) and in the presence of 1 mM
DOC (▲) as a function of IpaB11-226 indicates a DOC initiated, dose-dependent decrease in
FRET efficiency resulting from an increase in distance between the donor and acceptor
fluorophores (B), consistent with a movement such as the one illustrated in panel A (right
side).
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Figure 4. Identification of a region near the IpaB N-terminus necessary for proper Shigella T3SS
secretion control
Western blots of IpaB, IpaC, and IpaD present in the supernatant (A) and the whole cell
extracts (B) of overnight S. flexneri cultures.
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Figure 5. Identification of a region near the IpaB N-terminus necessary for optimal Shigella
T3SA surface presentation
Fluorescence intensity histograms depicting DOC-induced levels of surface localization of
IpaB for the SF620 (ipaB null) S. flexneri strain (shaded) and those complemented with
wild-type IpaB (solid), IpaBΔ12-19 (dashed), IpaBΔ12-25 (dotted), and IpaBΔ12-27 (dash-dot-
dash). The decreased levels of the IpaB mutants compared to wild-type is consistent with in
the in vitro experiments suggesting that this region near the N-terminus plays an important
role in proper IpaD/IpaB interaction and T3SA localization.
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Table 1
Calculated dissociation constants for the Shigella T3SS tip protein IpaD and N-terminal peptides of the
translocator IpaBa
IpaB Peptide T3SS Tip Protein Kd (μM ± SD)
IpaB1-226 IpaD 0.78 ± 0.43
IpaB11-226 IpaD 0.39 ± 0.10
IpaB28-226 IpaD 3.60 ± 0.37
a
Apparent dissociation constants were calculated by fitting the polarization data points to a single site saturation model using SigmaPlot. (n = 3
independent measurements)
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Table 2
FRET efficiencies characterizing the interaction between the Shigella T3SS proteins IpaD and IpaBa
Acceptor (Fluorescein) Location
FRET Efficiency (% ± SD)
No DOC 1 mM DOC
IpaB11-226 S107C −0.1 ± 0.0 33.1 ± 1.4
IpaB11-226 S120C 8.1 ± 0.1 33.3 ± 0.5
IpaB11-226 S128C 7.3 ± 0.1 21.4 ± 0.4
IpaB11-226 S149C 8.0 ± 0.1 14.6 ± 0.2
a
FRET efficiencies were measured between a coumarin donor probe located at the native cysteine (residue 322) in IpaD and a fluorescein acceptor
bound to the single cysteine residues mutated into IpaB11-226. Results are presented as %FRET efficiency ± standard deviation. (n = 3
independent measurements)
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Table 3
Identifying a region near the IpaB N-terminus required for proper Shigella flexneri virulence phenotype
Bacterial Strain Hemolysisb (% ± SD)
Relative Invasionc (% ± SD)
No DOC 1 mM DOC
ipaB null (SF620) 4.5 ± 0.3 0 ± 0 0 ± 0
SF620 + ipaB 100 ± 2.5 100 ± 4 288 ± 6
SF620 ipaBΔ12-19 5.8 ± 0.3 15 ± 1 21 ± 1
SF620 ipaBΔ12-25 10.1 ± 1.0 6 ± 1 7 ± 1
SF620 ipaBΔ12-27 5.9 ± 0.4 1 ± 1 2 ± 1
a
The ability of the Shigella mutants to lyse red blood cells was investigated by a hemolysis assay which spectrophotometrically quantifies the
release of hemoglobin from erythrocytes following incubation with the Shigella.
b
Results are presented as percent wild-type IpaB ± standard deviation (n = 3 independent measurements).
c
Invasiveness was measured by a standard gentamicin protection assay (see methods) and the results are presented as the percent invasion by S.
flexneri expressing wild-type IpaB in the absence of DOC. Experiments were repeated in triplicate.
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